Clinical Trials
Braintumor Website

These trials were the most recently added or updated

NCT Trial Name# of CentersLast Updated

NCT02654964

  Cancer Stem Cell High-Throughput Drug Screening Study
101/12/2016

NCT02334722

  1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients
101/12/2016

NCT02234050

  Trabectedin for Recurrent Grade II/III Meningioma
1801/12/2016

NCT02120287

  Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme
101/12/2016

NCT01678352

  Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas
101/12/2016

NCT01553149

  Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
6601/12/2016

NCT01326104

  Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor
201/12/2016

NCT01269853

  Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
101/12/2016

NCT00811148

  Florida Center for Brain Tumor Research
101/12/2016

NCT02621515

  Nivolumab in Symptomatic Brain Metastases
101/11/2016

NCT02546102

  Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
401/11/2016

NCT02395692

  Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
201/11/2016

NCT02180217

  Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
6801/11/2016

NCT02142803

  TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
201/11/2016

NCT02133183

  TORC1/2 Inhibitor INK128 Before and After Surgery in Treating Patients With Recurrent Glioblastoma
901/11/2016

NCT02095132

  WEE1 Inhibitor MK-1775 and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
2001/11/2016

NCT01922076

  WEE1 Inhibitor MK-1775 and Local Radiation Therapy in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
1701/11/2016

NCT01878266

  Prospective Trial of Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children
101/11/2016

NCT01849146

  WEE1 Inhibitor MK-1775, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme
1101/11/2016

NCT01514201

  Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas
1101/11/2016

NCT02073968

  PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer
201/10/2016

NCT02308020

  A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain
2501/08/2016

NCT02058953

  CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases
101/08/2016

NCT02650401

  Study of RXDX-101 in Children With Recurrent or Refractory Solid Tumors and Primary CNS Tumors
101/07/2016

NCT02343406

  ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma
6501/07/2016

NCT02209376

  Pilot Study of Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ Glioblastoma
101/07/2016

NCT02185352

  Bevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy in Breast Cancer With Brain Metastases
301/07/2016

NCT02020720

  18F-DOPA-PET in Planning Surgery in Patients With Gliomas
101/07/2016

NCT02015117

  Trametinib With or Without Whole Brain Radiation Therapy in Treating Patients With Brain Metastases
201/07/2016

NCT01991977

  18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy
101/07/2016

NCT01957735

  BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors
301/07/2016

NCT02650752

  Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases
601/06/2016

NCT02575027

  Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
101/06/2016

NCT02311582

  MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas
101/06/2016

NCT02017717

  A Study of the Efficacy and Safety of Nivolumab vs Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients at Different Stages of Treatment (CheckMate 143)
2001/06/2016

NCT01850563

  A Proof-of-principle Study of Hyperbaric Oxygen as a Radiosensitizer Prior to Stereotactic Radiosurgery for Brain Metastases
101/06/2016

NCT01503827

  Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma
2001/06/2016

NCT02649582

  Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients
101/05/2016

NCT02311556

  Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging
101/05/2016

NCT02197637

  Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
1001/05/2016

NCT02115074

  Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas
801/05/2016

NCT02511405

  A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)
401/04/2016

NCT01975701

  A Phase 2 Study of BGJ398 in Patients With Recurrent GBM
1601/04/2016

NCT02536339

  Pertuzumab With High-Dose Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-Radiotherapy
912/31/2015

NCT02414165

  P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA
712/31/2015

NCT02206230

  Trial of Hypofractionated Radiation Therapy for Glioblastoma
112/31/2015

NCT02645487

  Stereotactic Radiosurgery (SRS) for Brain Metastasis
112/30/2015

NCT02208362

  Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
112/30/2015

NCT01985256

  Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
412/28/2015

NCT01592968

  A Prospective Phase III Trial to Compare Stereotactic Radiosurgery Versus Whole Brain Radiation Therapy
112/28/2015



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2016 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites